This Article  • Full text  • PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (71)  • Contact me when this article is cited  Related Content  • Related letter  • Related article  • Similar articles in JAMA  Topic Collections  • Revascularization  • Cardiovascular System  • Surgery  • Surgical Interventions  • Cardiovascular/ Cardiothoracic Surgery  • Cardiovascular Intervention  • Alert me on articles by topic  Social Bookmarking   What's this?

Preoperative -Blocker Use and Mortality and Morbidity Following CABG Surgery in North America

T. Bruce Ferguson, Jr, MD; Laura P. Coombs, PhD; Eric D. Peterson, MD,MPH; for the Society of Thoracic Surgeons National Adult Cardiac Surgery Database

JAMA. 2002;287:2221-2227.

Context  -Blockade therapy has recently been shown to convey a survival benefit in preoperative noncardiac vascular surgical settings. The effect of preoperative -blocker therapy on coronary artery bypass graft surgery (CABG) outcomes has not been assessed.

Objectives  To examine patterns of use of preoperative -blockers in patients undergoing isolated CABG and to determine whether use of -blockers is associated with lower operative mortality and morbidity.

Design, Setting, and Patients  Observational study using the Society of Thoracic Surgeons National Adult Cardiac Surgery Database (NCD) to assess -blocker use and outcomes among 629 877 patients undergoing isolated CABG between 1996 and 1999 at 497 US and Canadian sites.

Main Outcome Measure  Influence of -blockers on operative mortality, examined using both direct risk adjustment and a matched-pairs analysis based on propensity for preoperative -blocker therapy.

Results  From 1996 to 1999, overall use of preoperative -blockers increased from 50% to 60% in the NCD (P<.001 for time trend). Major predictors of use included recent myocardial infarction; hypertension; worse angina; younger age; better left ventricular systolic function; and absence of congestive heart failure, chronic lung disease, and diabetes. Patients who received -blockers had lower mortality than those who did not (unadjusted 30-day mortality, 2.8% vs 3.4%; odds ratio [OR], 0.80; 95% confidence interval [CI], 0.78-0.82). Preoperative -blocker use remained associated with slightly lower mortality after adjusting for patient risk and center effects using both risk adjustment (OR, 0.94; 95% CI, 0.91-0.97) and treatment propensity matching (OR, 0.97; 95% CI, 0.93-1.00). Procedural complications also tended to be lower among treated patients. This treatment advantage was seen among the majority of patient subgroups, including women; elderly persons; and those with chronic lung disease, diabetes, or moderately depressed ventricular function. Among patients with a left ventricular ejection fraction of less than 30%, however, preoperative -blocker therapy was associated with a trend toward a higher mortality rate (OR, 1.13; 95% CI, 0.96-1.33; P = .23).

Conclusions  In this large North American observational analysis, preoperative -blocker therapy was associated with a small but consistent survival benefit for patients undergoing CABG, except among patients with a left ventricular ejection fraction of less than 30%. This analysis further suggests that preoperative -blocker therapy may be a useful process measure for CABG quality improvement assessment.

Author Affiliations: Society of Thoracic Surgeons National Database Committee, Chicago, Ill (Dr Ferguson); and the Duke Clinical Research Institute, Durham, NC (Drs Coombs and Peterson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Preoperative -Blockade and Risk of Postoperative Atrial Fibrillation
Tsung O. Cheng, T. Bruce Ferguson, Jr, Laura P. Coombs, and Eric D. Peterson
JAMA. 2002;288(5):573-574.
EXTRACT | FULL TEXT  

RELATED ARTICLE

May 1, 2002
JAMA. 2002;287(17):2295-2296.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Statin treatment equalizes long-term survival between patients with single and bilateral internal thoracic artery grafts.
Carrier et al.
Ann. Thorac. Surg. 2009;88:789-795.
ABSTRACT | FULL TEXT  

Which are the exact guidelines for more rationale intervention concerning beta-blockers administration in coronary patients preoperatively?
Apostolakis et al.
Eur. J. Cardiothorac. Surg. 2009;35:746-746.
FULL TEXT  

Atrial fibrillation following cardiac surgery: clinical features and preventative strategies
Kaireviciute et al.
Eur Heart J 2009;30:410-425.
ABSTRACT | FULL TEXT  

Still without impact on adverse post-operative outcomes: pre-operative statin therapy in patients undergoing cardiac surgery: reply
Liakopoulos et al.
Eur Heart J 2008;29:2444-2445.
FULL TEXT  

Comparison of S-(+)-ketamine- with sufentanil-based anaesthesia for elective coronary artery bypass graft surgery: effect on troponin T levels
Neuhauser et al.
Br J Anaesth 2008;100:765-771.
ABSTRACT | FULL TEXT  

Quo Vadis, Perioperative Beta Blockade? Are You "POISE'd" on the Brink?
London
Anesth. Analg. 2008;106:1025-1030.
FULL TEXT  

Mechanisms, Prevention, and Treatment of Atrial Fibrillation After Cardiac Surgery
Echahidi et al.
J Am Coll Cardiol 2008;51:793-801.
ABSTRACT | FULL TEXT  

Exploring the Behavior of Hospital Composite Performance Measures: An Example From Coronary Artery Bypass Surgery
O'Brien et al.
Circulation 2007;116:2969-2975.
ABSTRACT | FULL TEXT  

Comparison of Cardiac Surgery Volumes and Mortality Rates Between The Society of Thoracic Surgeons and Medicare Databases From 1993 Through 2001
Welke et al.
Ann. Thorac. Surg. 2007;84:1538-1546.
ABSTRACT | FULL TEXT  

Post-Cardiothoracic Surgery Atrial Fibrillation: A Review of Preventive Strategies
Baker and White
The Annals of Pharmacotherapy 2007;41:587-598.
ABSTRACT | FULL TEXT  

Quality Measurement in Adult Cardiac Surgery: Part 1--Conceptual Framework and Measure Selection
Shahian et al.
Ann. Thorac. Surg. 2007;83:S3-S12.
FULL TEXT  

Outcomes Associated With the Use of Secondary Prevention Medications After Coronary Artery Bypass Graft Surgery
Goyal et al.
Ann. Thorac. Surg. 2007;83:993-1001.
ABSTRACT | FULL TEXT  

Does preoperative atrial fibrillation influence early and late outcomes of coronary artery bypass grafting?
Ngaage et al.
J. Thorac. Cardiovasc. Surg. 2007;133:182-189.
ABSTRACT | FULL TEXT  

Guidelines on the prevention and management of de novo atrial fibrillation after cardiac and thoracic surgery
Dunning et al.
Eur. J. Cardiothorac. Surg. 2006;30:852-872.
FULL TEXT  

Left main coronary artery stenosis no longer a risk factor for early and late death after coronary artery bypass surgery - an experience covering three decades.
Jonsson et al.
Eur. J. Cardiothorac. Surg. 2006;30:311-317.
ABSTRACT | FULL TEXT  

Preoperative statin treatment is associated with reduced postoperative mortality and morbidity in patients undergoing cardiac surgery: an 8-year retrospective cohort study.
J. Thorac. Cardiovasc. Surg. 2006;131:679-685.
 

Chronic {beta}-adrenoreceptor blockade in surgical patients
Oremus et al.
Br J Anaesth 2005;95:835-836.
FULL TEXT  

Weighing In on Bariatric Surgery: Procedure Use, Readmission Rates, and Mortality
Wolfe and Morton
JAMA 2005;294:1960-1963.
FULL TEXT  

Quality, Safety, and Transparency: A Rising Tide Floats All Boats
Pairolero
Ann. Thorac. Surg. 2005;80:387-395.
FULL TEXT  

Pharmacologic Strategies for Prevention of Atrial Fibrillation After Open Heart Surgery
DiDomenico and Massad
Ann. Thorac. Surg. 2005;79:728-740.
ABSTRACT | FULL TEXT  

Are prophylactic {beta}-blockers of benefit in reducing the incidence of AF following coronary bypass surgery?
Omorphos et al.
ICVTS 2004;3:641-646.
ABSTRACT | FULL TEXT  

Cardiac Surgery Risk Models: A Position Article
Shahian et al.
Ann. Thorac. Surg. 2004;78:1868-1877.
ABSTRACT | FULL TEXT  

Preoperative calcium-channel blockade in cardiac surgery: the good, the bad, the issues
Ferguson
J. Thorac. Cardiovasc. Surg. 2004;127:622-624.
FULL TEXT  

Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis
Wijeysundera et al.
J. Thorac. Cardiovasc. Surg. 2004;127:755-762.
ABSTRACT | FULL TEXT  

Off-pump coronary artery bypass surgery: physiology and anaesthetic management{dagger}
Chassot et al.
Br J Anaesth 2004;92:400-413.
ABSTRACT | FULL TEXT  

Preoperative {beta}-blocker therapy in coronary artery bypass surgery: a propensity score analysis of outcomes
Srinivasan et al.
ICVTS 2003;2:495-500.
ABSTRACT | FULL TEXT  

Long-term benefits of coronary bypass surgery: Are the gains for women less than for men?
Vaccarino and Koch
J. Thorac. Cardiovasc. Surg. 2003;126:1707-1711.
FULL TEXT  

Aspirin and Mortality from Coronary Bypass Surgery
Chesebro et al.
NEJM 2003;348:1057-1059.
FULL TEXT  

Epidemiology and Pharmacotherapy of Acute Heart Failure
Vroom
SEMIN CARDIOTHORAC VASC ANESTH 2003;7:3-12.
 

Effect of preoperative {beta}-blockade on perioperative mortality in coronary surgery
ten Broecke et al.
Br J Anaesth 2003;90:27-31.
ABSTRACT | FULL TEXT  

The Association Between Heart Rate and In-Hospital Mortality After Coronary Artery Bypass Graft Surgery
Fillinger et al.
Anesth. Analg. 2002;95:1483-1488.
ABSTRACT | FULL TEXT  

Preoperative {beta}-Blockade and Risk of Postoperative Atrial Fibrillation
Cheng et al.
JAMA 2002;288:573-574.
FULL TEXT  

Post-CABG Outcomes May Improve with Preoperative Beta-Blocker Use
Journal Watch Cardiology 2002;2002:1-1.
FULL TEXT  

Perioperative {beta}-Blockers for CABG Patients
JWatch General 2002;2002:1-1.
FULL TEXT